<DOC>
	<DOCNO>NCT00481520</DOCNO>
	<brief_summary>The primary purpose study ass whether SAM-531 , investigational drug , safe well tolerate , compare placebo ( medically inactive substance ) , subject mild moderate Alzheimer 's disease .</brief_summary>
	<brief_title>Study Evaluating Safety , Tolerability , PK PD SAM-531 Subjects With Mild Moderate Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Inclusion Criteria 1 . Signed date write informed consent obtain subject subject ` legally authorize representative ( LAR ) next kin ( applicable ) , accordance local regulation . The subject ` caregiver must also consent participate study . 2 . Diagnosis probable Alzheimer 's Disease accord National Institute Neurological Communicative Disorders StrokeAlzheimer 's Disease Related Disorders Association ( NINCDSADRDA ) criterion . 3 . Men postmenopausal surgically sterile woman age 50 90 inclusive . Postmenopausal woman must 12 month spontaneous amenorrhea . Surgically sterile woman define hysterectomy , bilateral ovariectomy [ oophorectomy ] , bilateral tubal ligation . Men sexually active need agree use form contraception satisfactory per investigator . 4 . Able participate schedule evaluation high probability completing require procedure neuropsychological test . Exclusion Criteria 1 . Significant neurological disease Alzheimer 's disease , may affect cognition ( eg , epilepsy , Parkinson disease ) . 2 . Current diagnosis major depressive disorder major psychiatric symptom accord criterion Diagnostic Statistical Manual Mental Disorders , Fourth Edition Text Version ( DSMIVTR ) . 3 . Current clinically significant systemic illness , likely deteriorate affect subject 's safety , influence cognitive assessment ability complete study . 4 . Any clinically important deviation normal limit physical neurological examination , vital sign , electrocardiogram ( ECG ) clinical laboratory test result could compromise study detrimental subject .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2008</verification_date>
</DOC>